(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)-2 -Cyclopentene-1-methanol CAS NO.136522-33-3

Jiangxi factory covers a total area of 50000 square meters and has 8500 square meters for building. Based on GMP standard design and construction, Bioman has passed the ISO9001 and ISO14001 certification. Bioman is a high-tech enterprise in Jiangxi province. Put into operation in 2015, Bioman equipped with a comprehensive analysis and testing center, multi-functional synthesis workshop and standard GMP workshop. There are more than 42 sets of production equipment(200L-6300L), and can complete various chemical reactions at -70 ~ 200 degrees, anhydrous, anaerobic and other conditions; has high temperature, high pressure and other special reaction equipment; equipped with Φ10-30cm industrial chromatography system for purification, and bioreactor(500L×2) for biotransformation and enzymic catalytic reaction; has the qualification of using highly toxic chemicals. Bioman has an independent and comprehensive quality assurance system, including QA and QC, to ensure the quality of our products. QC department is fully equipped (with HPLC, GC, spectropolarimeter, water titrator, etc.) to meet R&D and manufacturing demand.
   Driven by technology, Bioman regards quality as the life, and takes the customer's demand as the responsibility. From custom synthesis to large-scale production, from technology to documentation, from laboratory to GMP management, we are committed to provide customers with a full range of services.

Established in 2010，Bioman Pharma Limited(Bioman) is a high-tech company dedicated to research and development of active pharmaceutical ingredients (APIs) and chiral intermediates. Headquartered in Shanghai, and the company has a factory in Shangrao, Jiangxi Province. 

Shanghai R&D Center, occupied 700 square meters, have 2 Chemical Labs, 1 Biochemical Lab,

1 Analysis & Purification Lab. Combined with the technology of organic synthesis, biotransformation and purification, Bioman makes great progress in new product and new process.